| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Canada | 2 | |
| #3 | Australia | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Hong Kong | 1 | |
| #7 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Cullis-Hill David | 10 |
| #2 | Mcewan John Fergus | 7 |
| #3 | Windsor Martin Lyndale | 7 |
| #4 | Hannon Robert Logan | 4 |
| #5 | Little Christopher Bond | 4 |
| #6 | Smith Margaret Mary | 4 |
| #7 | Chllis-Hill David | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009018625A1 | Treatment of prion protein related diseases | |
| US2008076723A1 | Inhibition of cathepsin K activity and the treatment and prevention of disease | |
| CA2561032A1 | Inhibition of cathepsin k activity and the treatment and prevention of disease | |
| AU2006222712A1 | Inhibition of Cathepsin K Activity and the treatment and prevention of disease |